The purpose of this study is to assess the efficacy of droperidol as a treatment of cannabinoid hyperemesis syndrome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline in symptoms after treatment with droperidol and diphenhydramine
Timeframe: Baseline, 30 minutes, 60 minutes and 120 minutes. Then at 24 hours and 48 hours.